GGASX — GMO Global Equity Allocation Series Fund
Data updated: 2020-07-28
GGASX — GMO Global Equity Allocation Series Fund. Money Market · $5.33M AUM · 0.63% expense ratio. Holdings, fees, performance and SEC filings.
GGASX Fund Overview
GGASX — GMO Global Equity Allocation Series Fund is a US mutual fund managed by GMO Series Trust, categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: GMO Series Trust
- Category: Money Market
- Assets under management: $5.33M
- Ticker: GGASX
- SEC CIK: 0001521894
- SEC series ID: S000035216
- Share class ID: C000108338
GGASX Investment Objective and Strategy
GMO Global Equity Allocation Series Fund describes its objective and strategy as follows, from its latest prospectus filed with the SEC by GMO Series Trust.
Investment objective
Total return greater than that of its benchmark, the MSCI ACWI.
Principal investment strategy
"The Fund invests substantially all of its assets in Class III shares of GMO Global Equity Allocation Fund (""GEAF""), a series of GMO Trust not offered in this Prospectus. GEAF invests primarily in shares of other funds managed by GMO (""GMO Funds""). The Fund's investment objective and principal investment strategies are substantially similar to those of GEAF. Except as otherwise indicated, references to the Fund may also refer to GEAF, and references to actions undertaken or investments held by the Fund may also refer to those by GEAF. GMO serves as investment adviser for both the Fund and GEAF. The Fund is a fund of funds and invests primarily in equities traded in U.S. and non-U.S. markets (including emerging markets) through shares of GMO Funds that invest in equities (collectively, the ""GMO Equity Funds""), GMO Alpha Only Fund and GMO Risk Premium Fund (collectively, the ""underlying GMO Funds"").
The Fund also may invest directly in securities (including other underlying funds) and derivatives. GMO uses its multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of such asset classes, to determine the Fund's allocations to particular underlying GMO Funds. An important component of those forecasts is GMO's expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value. GMO changes the Fund's holdings of the underlying GMO Funds in response to changes in GMO's investment outlook and market valuations and may use redemptions or purchases of Fund shares to rebalance the Fund's investments. The factors GMO considers and investment methods GMO uses can change over time. Under normal circumstances, the Fund invests (including through investment in the underlying GMO Funds) at least 80% of its assets in equities.
The term ""equities"" refers to direct and indirect (e.g., through the underlying GMO Funds) investments in common and preferred stocks and other stock-related securities, such as convertible securities, depositary receipts, and equity real estate investment trusts (REITs) and income trusts. The Fund may invest in securities of companies of any market capitalization. In addition, the Fund may lend its portfolio securities. The Fund also may invest in GMO U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments typically held by money market funds. The Fund may hold cash, cash equivalents, and/or U.S. government securities to manage cash inflows and outflows as a result of shareholder purchases and redemptions."
GGASX Costs and Fees
GGASX costs about $63 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.63%
- Gross expense ratio: 0.99%
- Portfolio turnover: 8%
- Brokerage commissions: 0.00 bps of average net assets (SEC N-CEN)
GGASX Cashflows
Over the 12 months to 2020-05, GMO Global Equity Allocation Series Fund had net outflows of $68.41K, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2020-05 | −$11.55K |
| 2020-04 | −$80.42K |
| 2020-03 | $4.26K |
| 2020-02 | $23.27K |
| 2020-01 | $20.83K |
| 2019-12 | $180.88K |
GGASX Debt Constituents
No individual debt constituents are reported in GMO Global Equity Allocation Series Fund's latest SEC N-PORT filing.
GGASX Prospectus and SEC Filings
Official GMO Global Equity Allocation Series Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2020-07-17
- Prospectus (485BPOS) — filed 2019-07-22
- Prospectus (485BPOS) — filed 2018-07-23
- Portfolio holdings (N-PORT) — filed 2020-07-28
- Portfolio holdings (N-PORT) — filed 2020-04-24
- Portfolio holdings (N-PORT) — filed 2020-01-28
- Annual census (N-CEN) — filed 2020-05-12
- Annual census (N-CEN) — filed 2019-05-10
Related Funds
Other Money Market funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.